Search
for
Sort by
Research 181–210 of 1000+
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Androgenetic Alopecia: Therapy Update
- Polycystic Ovarian Syndrome - What is New
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- To evaluate the outcome of combined therapy of cyproterone acetate and ethinyl estradiol in PCOS
- Endocrine disruptors as risk factors for idiopathic premature thelarche in girls: A case-control study
- Adult polycystic ovary syndrome begins in childhood
- Adverse effects of common medications on male fertility
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Male hormonal contraception: looking back and moving forward
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Postpartum Alopecia
- Ovarian Hilus-Cell Hyperplasia and High Serum Testosterone in a Patient With Postmenopausal Virilization
- Gonadal Dysgenesis: Associations between Clinical Features and Sex of Rearing.
- Treatment of hyperandrogenism in women
- Hyperadrenocorticism in Ferrets
- Secondary amenorrhea
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Androgenic Effects on Ventricular Repolarization
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Mood disorders and quality of life in polycystic ovary syndrome